Safety and efficacy of single agent rovalpituzumab tesirine in small cell lung cancer (SCLC)
1 مناظر
• 07/14/23
0
0
ایمبیڈ
administrator
سبسکرائبرز
Press brief by Charles Rudin, MD, PhD of the Memorial Sloan Kettering Cancer Center, New York, NY, at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, IL.
مزید دکھائیں
فیس بک کے تبصرے
SORT BY-
سرفہرست تبصرے
-
تازہ ترین تبصرے